Nathan Breazeale, MD
Sports Medicine · Austin, TXNPI 1194795062
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,614 of the $4,257 with a category attached, or 61.4%. 19 manufacturers reported payments, led by Arthrex at 44.7% of the total. Reporting peaked in 2019 at $3,560 and has fallen 95.2% since, to $172 in 2025.
Across 47 payments — averaging $90.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Medinc Of Texas$2K
- Core Surgical Group$154
- Johnson & Johnson$115
- Ferring Pharmaceuticals Inc.$86
- Abbott$68
- plus $372 from 13 others
What the payments were for
- Travel & lodging$81619%
- Food & beverage$82719%
- Education$2,61461%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 4 | $1,904 |
| Medinc Of Texas | 4 | $1,558 |
| Core Surgical Group | 1 | $154 |
| Johnson & Johnson(2 entities) | 5 | $115 |
| Ferring Pharmaceuticals Inc. | 7 | $86 |
| Abbott | 3 | $68 |
| Bioventus LLC | 2 | $61 |
| Stryker | 1 | $42 |
| Orthogenrx Inc. | 2 | $40 |
| Pacira Pharmaceuticals Incorporated | 2 | $37 |
| Si-bone, Inc. | 1 | $32 |
| Anika Therapeutics, Inc. | 1 | $29 |
| Orthofix Medical, Inc. | 7 | $26 |
| Vericel Corporation | 1 | $24 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Davol Inc. | 1 | $20 |
| Smith+Nephew | 1 | $15 |
| Nevro Corp. | 1 | $14 |
| Fidia Pharma USA Inc. | 2 | $12 |
How this compares
$4,257 in reported general payments places this provider in the 60th percentile of 437 sports medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 14 | $328 |
| Meloxicam | 143 | $310 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $148 |
| Tramadol Hcl | 18 | $51 |
| Ibuprofen | 23 | $46 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Austin
- John McDonaldAustin$499K
- Douglas ElenzAustin$129K
- Darryl ThomasAustin$37K
- James WalkerAustin$31K
- Thomas DeberardinoSan Antonio$3.5M
- Robert ScheinbergDallas$2.2M
- Walter LoweHouston$1.4M
- Reed BartzSunnyvale$1.2M
- James GregoryHouston$565K
- James McKinleyTyler$305K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.